Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
Eustache Paramithiotis, Scott Sugden, Eszter Papp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
Md. Ahsanul Haq, Anjan Kumar Roy, Razu Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
Rituparna Das, Randall N. Hyer, Paul R. Burton, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 14
Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis
Alicia Vachon, Alexa Keeshan, Yannick Galipeau, et al.
Vaccine (2025) Vol. 55, pp. 127034-127034
Open Access
Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up
Rogier A.S. Hoek, Siqi Liu, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
Silicon or Calcium Doping Coordinates the Immunostimulatory Effects of Aluminum Oxyhydroxide Nanoadjuvants in Prophylactic Vaccines
Min Li, Zhiying Yao, Huiyang Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16878-16894
Closed Access | Times Cited: 2
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity
Gian Luca Salvagno, Laura Pighi, Brandon Michael Henry, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1343-1348
Open Access | Times Cited: 6
Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis
Suwasin Udomkarnjananun, Sivaporn Gatechompol, Asada Leelahavanichkul, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development
Eustache Paramithiotis, Christophe Varaklis, Stéphane Pillet, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
Lavanya Kodali, Pooja Budhiraja, Juan Gea‐Banacloche
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Intranasal Immunization With Nanoparticles Containing an Orientia tsutsugamushi Protein Vaccine Candidate and a Polysorbitol Transporter Adjuvant Enhances Both Humoral and Cellular Immune Responses
Cheol Gyun Kim, Won Kyong Kim, Narae Kim, et al.
Immune Network (2023) Vol. 23, Iss. 6
Open Access | Times Cited: 4
No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort
Deepak Nagra, Katie Bechman, Mark Russell, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 69-69
Open Access | Times Cited: 1
Serological responses to COVID-19 vaccination in patients with chronic liver diseases
Yu‐Shan Huang, Szu‐Min Hsieh, Feng‐Chiao Tsai, et al.
Journal of the Formosan Medical Association (2024) Vol. 123, Iss. 11, pp. 1194-1197
Open Access | Times Cited: 1
Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients
Louise Benning, Marie Bartenschlager, Heeyoung Kim, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 738-738
Open Access | Times Cited: 1
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine
Letizia Corinna Morlacchi, Gianfranco Alicandro, Sara Uceda Renteria, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
Kinetics of SARS-CoV-2 antibody titers after booster vaccinations during an Omicron surge in Japan
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126156-126156
Closed Access | Times Cited: 1
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants
Liqing Chen, Xiaoxiao Qi, Dan Liang, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 3
Antibody responses to SARS-CoV-2 spike protein in a cohort of renal transplant recipients following two-dose primary immunization − A Caribbean country’s perspective
Lesley Roberts, Carla‐Maria Alexander, Michèle Monteil, et al.
Vaccine X (2024) Vol. 18, pp. 100487-100487
Open Access
Dendritic Cell-Based Biomimetic Nanoparticles for Foot-and-mouth Disease Induce Robust Cellular Immunity
Zhan Gao, Xiaoqing Liu, Yao Lei, et al.
Antiviral Research (2024) Vol. 231, pp. 106011-106011
Closed Access
T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access
Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications
Yu Chen, Tian Fan, Shunlin Hu, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1932-1932
Open Access
HUMORAL AND CELLULAR RESPONSE TO SARS-CoV-2 mRNA VACCINE IN PAEDIATRIC HEART TRANSPLANT RECIPIENTS
Amanda Bermejo, Laura Tarancón‐Díez, Beatriz Lazaro-Martin, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41584-e41584
Open Access
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
Wadha Alfouzan, Haya Altawalah, Ahmad Al‐Sarraf, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 336-336
Open Access | Times Cited: 1
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
Robert L. Murphy, Eustache Paramithiotis, Scott Sugden, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity
Gian Luca Salvagno, Laura Pighi, Brandon Michael Henry, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top